0.3801
price up icon8.29%   0.0291
pre-market  Vorhandelsmarkt:  .39   0.0099   +2.60%
loading

Finanzdaten der Akari Therapeutics Plc Adr-Aktie (AKTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.525
- - - -
Operating Income/Loss
33.21%
-3.525
-5.278 -2.927 -7.449 -5.989
Nonoperating Income/Loss
111.95%
-0.18
1.506 0.032 -0.109 0.423
Income/Loss From Continuing Operations Before Tax
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Net Income/Loss
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
997.01%
54,588.28
4,976.08 24,386.01 18,836.48 13,453.15
Diluted Average Shares
997.01%
54,588.28
4,976.08 24,386.01 18,836.48 13,453.15
Basic Earnings Per Share
-
- - - -
Diluted Earnings Per Share
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):